These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2441930)

  • 1. Public epitopes and the antigenic structure of the HLA molecules.
    Rodey GE; Fuller TC
    Crit Rev Immunol; 1987; 7(3):229-67. PubMed ID: 2441930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution.
    Braunstein NS; Germain RN; Loney K; Berkowitz N
    J Immunol; 1990 Sep; 145(6):1635-45. PubMed ID: 1697304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
    Wan AM; Ennis P; Parham P; Holmes N
    J Immunol; 1986 Dec; 137(11):3671-4. PubMed ID: 2431040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to human major histocompatibility complex class II antigens.
    Radka SF
    Crit Rev Immunol; 1987; 8(1):23-48. PubMed ID: 2446824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17.
    Ways JP; Rothbard JB; Parham P
    J Immunol; 1986 Jul; 137(1):217-22. PubMed ID: 2423602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule.
    Hogan KT; Clayberger C; Le AX; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Dec; 141(11):4005-11. PubMed ID: 2460555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
    Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
    J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class II DQ epitopes.
    Deng CT; Cai J; Tarsitani C; El-Awar N; Lachmann N; Ozawa M
    Clin Transpl; 2006; ():115-22. PubMed ID: 18365373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antigenic structure of HLA-A2: an analysis with competitive binding assays and monoclonal antibodies.
    Ways JP; Parham P
    J Immunol; 1983 Aug; 131(2):856-63. PubMed ID: 6190942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule.
    Santos-Aguado J; Barbosa JA; Biro PA; Strominger JL
    J Immunol; 1988 Oct; 141(8):2811-8. PubMed ID: 2459229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II antigens: structure, function, and expression in immunodeficiencies, autoimmune diseases, and allograft rejection.
    Touraine JL; Bétuel H; Pouteil-Noble C; Royo C
    Adv Nephrol Necker Hosp; 1989; 18():325-34. PubMed ID: 2493721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of the HLA molecular structure to transplantation.
    Park MS; Terasaki PI; Barbetti A; Han H; Cecka JM
    Clin Transpl; 1988; ():301-28. PubMed ID: 2484900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
    El-Awar N; Lee JH; Tarsitani C; Terasaki PI
    Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of novel class I histocompatibility antigens by interspecies exon shuffling.
    Engelhard VH; Yannelli JR; Evans GA; Walk SF; Holterman MJ
    J Immunol; 1985 Jun; 134(6):4218-25. PubMed ID: 2985705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of high sensitization to the structure of HLA class I alleles.
    Clark BD; Geer LI; Park MS; Terasaki PI
    Clin Transpl; 1991; ():347-62. PubMed ID: 1726461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.